Virtu Financial’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-17,923
| Closed | -$45K | – | 1349 |
|
|
2023
Q4 | $45K | Buy |
+17,923
| New | +$45K | ﹤0.01% | 1189 |
|
|
2023
Q2 | – | Sell |
-12,208
| Closed | -$37K | – | 1455 |
|
|
2023
Q1 | $37K | Sell |
12,208
-31,986
| -72% | -$96.9K | ﹤0.01% | 1148 |
|
|
2022
Q4 | $103K | Buy |
+44,194
| New | +$103K | 0.01% | 953 |
|
|
2022
Q3 | – | Sell |
-52,722
| Closed | -$143K | – | 1665 |
|
|
2022
Q2 | $143K | Buy |
+52,722
| New | +$143K | 0.01% | 856 |
|
|
2021
Q3 | – | Sell |
-93,196
| Closed | -$282K | – | 1439 |
|
|
2021
Q2 | $282K | Buy |
93,196
+29,255
| +46% | +$88.5K | 0.03% | 762 |
|
|
2021
Q1 | $213K | Buy |
63,941
+1,411
| +2% | +$4.7K | 0.02% | 1043 |
|
|
2020
Q4 | $222K | Buy |
+62,530
| New | +$222K | 0.02% | 791 |
|
|
2020
Q3 | – | Sell |
-17,147
| Closed | -$31K | – | 987 |
|
|
2020
Q2 | $31K | Buy |
+17,147
| New | +$31K | ﹤0.01% | 1075 |
|
|
2019
Q3 | – | Sell |
-24,548
| Closed | -$51K | – | 1385 |
|
|
2019
Q2 | $51K | Buy |
+24,548
| New | +$51K | ﹤0.01% | 1212 |
|
|
2018
Q1 | – | Sell |
-11,287
| Closed | -$57K | – | 1883 |
|
|
2017
Q4 | $57K | Buy |
+11,287
| New | +$57K | ﹤0.01% | 2051 |
|